This is the third Drug Safety-related Labeling Change (SrLC) since December 19, 2025, for the drug, according to the FDAs label change database
That simplicity makes it easier to put your pre-tax funds toward medically supported weight management without unnecessary friction
If you experience a severe allergic reaction (swelling of face, eyes, and lips, itching, dizziness, and difficulty breathing), gallbladder inflammation, changes in vision, or low blood sugar levels, stop using the medication and get medical help right away
Zepbound (tirzepatide) is not recommended during pregnancy and should be discontinued when pregnancy is recognized
If nausea follows a dose, try smaller meals, cooler foods, or bland options such as crackers, plain yogurt, or applesauce until symptoms ease